Volume 8, Issue 1 (2023)
SJMR 2023, 8(1): 67-72 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shafti V, Nateghi M R, Karimi-Mansourabad E. Multiple Sclerosis and Women's Reproductive Health: From Conception to Postpartum. SJMR 2023; 8 (1) : 7
URL: http://saremjrm.com/article-1-292-en.html
URL: http://saremjrm.com/article-1-292-en.html
1- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran. & School of Medicine, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran
2- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran.
2- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran.
Abstract: (1362 Views)
Multiple sclerosis (MS) is a chronic neurological disorder affecting over 2.8 million individuals globally. The relapse rate of MS is typically reduced during late pregnancy but increases in the postpartum period. Historically, women with MS have been advised against pregnancy due to concerns about reproduction. Studies have examined the influence of childbirth methods on the risk of MS. Pregnant MS patients have several delivery and anesthesia options available to them. Vaginal delivery can be considered as a safe option unless there are specific obstetric indications for cesarean section. Neuraxial anesthesia, such as epidural anesthesia, can be used for pain management during delivery. Close monitoring of disease activity during pregnancy and the postpartum period is essential, and the use of DMTs should be carefully evaluated on an individual basis. Collaboration between the patient's neurologist and obstetrician is crucial to ensure optimal outcomes for both the mother and the baby. Also, further research is needed to understand the issues related to treatment during breastfeeding.
Article number: 7
Keywords: Multiple sclerosis (MS), Reproductive Health, Conception, Postpartum, Disease modifying therapy (DMT).
Article Type: Analytical Review |
Subject:
Pregnancy Care
Received: 2023/05/2 | Accepted: 2023/06/14 | Published: 2023/11/7
Received: 2023/05/2 | Accepted: 2023/06/14 | Published: 2023/11/7
References
1. 1. Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(3):269-85. [DOI:10.1016/S1474-4422(18)30443-5]
2. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. Jama. 2005;294(21):2751-7. [DOI:10.1001/jama.294.21.2751]
3. 3. Türk Börü Ü, Bölük C, Taşdemir M, Gezer T, Serim VA. Air pollution, a possible risk factor for multiple sclerosis. Acta Neurol Scand. 2020;141(5):431-7. [DOI:10.1111/ane.13223]
4. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-52. [DOI:10.1212/WNL.33.11.1444]
5. Thöne J, Kollar S, Nousome D, Ellrichmann G, Kleiter I, Gold R, et al. Serum anti-Müllerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis. Mult Scler. 2015;21(1):41-7. [DOI:10.1177/1352458514540843]
6. Kapali A, Daltveit AK, Myhr KM, Bjornevik K, Baldin E, Pugliatti M, et al. Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based study. J Neurol Neurosurg Psychiatry. 2023. [DOI:10.1136/jnnp-2023-331241]
7. Lopez-Leon S, Geissbühler Y, Sabidó M, Turkson M, Wahlich C, Morris JK. A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project. J Neurol. 2020;267(9):2721-31. [DOI:10.1007/s00415-020-09913-1]
8. Coyle PK. Management of women with multiple sclerosis through pregnancy and after childbirth. Ther Adv Neurol Disord. 2016;9(3):198-210. [DOI:10.1177/1756285616631897]
9. Ross L, Ng HS, O'Mahony J, Amato MP, Cohen JA, Harnegie MP, et al. Women's Health in Multiple Sclerosis: A Scoping Review. Front Neurol. 2021;12:812147. [DOI:10.3389/fneur.2021.812147]
10. Jalkanen A, Kauko T, Turpeinen U, Hämäläinen E, Airas L. Multiple sclerosis and vitamin D during pregnancy and lactation. Acta Neurol Scand. 2015;131(1):64-7. [DOI:10.1111/ane.12306]
11. Lu E, Dahlgren L, Sadovnick A, Sayao A, Synnes A, Tremlett H. Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs. Mult Scler. 2012;18(4):460-7. [DOI:10.1177/1352458511422244]
12. Pastò L, Portaccio E, Ghezzi A, Hakiki B, Giannini M, Razzolini L, et al. Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. BMC Neurol. 2012;12:165. [DOI:10.1186/1471-2377-12-165]
13. Paavilainen T, Kurki T, Parkkola R, Färkkilä M, Salonen O, Dastidar P, et al. Magnetic resonance imaging of the brain used to detect early post-partum activation of multiple sclerosis. Eur J Neurol. 2007;14(11):1216-21. [DOI:10.1111/j.1468-1331.2007.01927.x]
14. Schubert C, Steinberg L, Peper J, Ramien C, Hellwig K, Köpke S, et al. Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2023;94(9):718-25. [DOI:10.1136/jnnp-2022-330533]
15. Langer-Gould A, Beaber BE. Effects of pregnancy and breastfeeding on the multiple sclerosis disease course. Clin Immunol. 2013;149(2):244-50. [DOI:10.1016/j.clim.2013.01.008]
16. illescas, A., Zhong, H., Liu, J., Cozowicz, C., Poeran, J., & Memtsoudis, S. G. (2023). Neuraxial use among total knee and hip arthroplasty patients with multiple sclerosis or myasthenia gravis. Anesthesia &Amp; Analgesia, 136(6), 1182-1188.
https://doi.org/10.1213/ANE.0000000000006471 [DOI:10.1213/ane.0000000000006471]
17. Langer-Gould AM. Pregnancy and Family Planning in Multiple Sclerosis. Continuum (Minneap Minn). 2019;25(3):773-92. [DOI:10.1212/CON.0000000000000745]
18. Villaverde-González R. Updated Perspectives on the Challenges of Managing Multiple Sclerosis During Pregnancy. Degener Neurol Neuromuscul Dis. 2022;12:1-21. [DOI:10.2147/DNND.S203406]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
